PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 20 |
| 2009 | 24 |
| 2010 | 25 |
| 2011 | 39 |
| 2012 | 19 |
| 2013 | 24 |
| 2014 | 23 |
| 2015 | 40 |
| 2016 | 22 |
| 2017 | 26 |
| 2018 | 25 |
| 2019 | 30 |
| 2020 | 45 |
| 2021 | 36 |
| 2022 | 36 |
| 2023 | 32 |
| 2024 | 28 |
| 2025 | 30 |
| 2026 | 17 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Trends Pharmacol Sci"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
The emerging landscape for next-generation HNSCC treatment.
- Jackett KN, Katerji M, Arnold K, Burkitt K, Gennaro A, Saloura V, Brognard J.
- Trends Pharmacol Sci. Author manuscript. 2026 Sep 22:S0165-6147(26)00236-1. doi: 10.1016/j.tips.2026.09.007. Online ahead of print.
- PMCID: PMC13693649
Jackett KN, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13693649 -
Nerandomilast as the first PDE4B-selective therapy in idiopathic pulmonary fibrosis.
- Ibrahim M, Piazza GA, Ahsan F.
- Trends Pharmacol Sci. Author manuscript. 2025 Dec 6;47(1):120-121. doi: 10.1016/j.tips.2025.11.006.
- PMCID: PMC12704825
Ibrahim M, et al.Trends Pharmacol Sci. Author manuscript. 2025.PMCID: PMC12704825 -
Heterochiral peptides reshaping class B1 GPCR agonism.
- Liu H, Cai J.
- Trends Pharmacol Sci. Author manuscript. 2026 Oct 1:S0165-6147(26)00232-4. doi: 10.1016/j.tips.2026.09.003. Online ahead of print.
- PMCID: PMC13632646
Liu H, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13632646 -
Lipophagy and lipid droplets in neurodegeneration.
- McKee NW, Jing Y, Serdah R, Thulasingam S, Lopez XS, Tan EP.
- Trends Pharmacol Sci. Author manuscript. 2026 Sep 22;47(10):1116-1135. doi: 10.1016/j.tips.2026.08.004.
- PMCID: PMC13632763
McKee NW, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13632763 -
Centanafadine (Simtriyo): a triple monoamine reuptake inhibitor for ADHD.
- Han J, Jiang C, Pruitt AA, Yu Y, Jiang J.
- Trends Pharmacol Sci. Author manuscript. 2026 Sep 12;47(10):1186-1187. doi: 10.1016/j.tips.2026.08.011.
- PMCID: PMC13591490
Han J, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13591490 -
Sequential EGFR inhibition sensitizes glioblastoma to temozolomide.
- Yu X, Wu R, Cheng SY.
- Trends Pharmacol Sci. Author manuscript. 2026 Aug 17;47(9):952-954. doi: 10.1016/j.tips.2026.07.010.
- PMCID: PMC13483342
Yu X, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13483342 -
Amyloidogenic amylin signaling links diabetes to dementia pathogenesis.
- Despa F, Lashley T.
- Trends Pharmacol Sci. Author manuscript. 2026 Aug 10;47(9):955-958. doi: 10.1016/j.tips.2026.07.009.
- PMCID: PMC13463382
Despa F, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13463382 -
STAT3 signaling inhibitors for cancer treatment.
- Akinsola R, Xian J, Turkson J.
- Trends Pharmacol Sci. Author manuscript. 2026 Aug 8;47(9):959-978. doi: 10.1016/j.tips.2026.07.004.
- PMCID: PMC13454982
Akinsola R, et al.Trends Pharmacol Sci. Author manuscript. 2026.PMCID: PMC13454982 -
Therapeutic potential of targeting macrophages and microglia in glioblastoma.
- Zhou F, Mukherjee P, Mu J, Chen P.
- Trends Pharmacol Sci. Author manuscript. 2025 Aug 9;46(9):848-862. doi: 10.1016/j.tips.2025.07.006.
- PMCID: PMC12342649
Zhou F, et al.Trends Pharmacol Sci. Author manuscript. 2025.PMCID: PMC12342649 -
Beyond G protein and arrestin: GRK2-biased β₂AR signaling.
- Ji RL, Wang Z, Zhao JJ.
- Trends Pharmacol Sci. Author manuscript. 2025 Aug 1;46(10):928-930. doi: 10.1016/j.tips.2025.07.010.
- PMCID: PMC12321243
Ji RL, et al.Trends Pharmacol Sci. Author manuscript. 2025.PMCID: PMC12321243